Henrik Uth, director and board member of Danish company Phytoreceptors ApS, is a senior director and specialist in business development and regulatory affairs in the pharmaceutical industry. He co-founded the first Danish company obtaining license to produce and supply intermediate medicinal cannabis products under the Danish Pilot program for medicinal cannabis, and has co-developed IMPD’s (Investigational Medicinal Product Dossiers) for several investigator initiated clinical trials using cannabinoids.

Mr. Uth’s current work focuses supply of ingredients and API’s (Active Pharmaceutical Ingredients), including controlled substances, such as extracts and pure substances containing cannabidiol, delta-9-tetrahydrocannabinol and other cannabinoids. This work includes product – and analytical development for regulatory approval by competent authorities when investigators are looking for development of IMPD’s as needed for product approval for clinical trials. In addition to his role in Phytoreceptors ApS, Mr. Uth is CEO of the Danish ingredient company, Engredo ApS.